Articles

Novel anti-Acanthamoeba effects elicited by a repurposed poly (ADP-ribose) polymerase inhibitor AZ9482

in Clinical and Diagnostic Microbiology and Immunology

• Lijun Chen
• Wei Han
• Wenwen Jing
• Meng Feng
• Qingtong Zhou
• Xunjia Cheng

Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy

in Medicinal and Pharmaceutical Chemistry

• Bijay Singh
• Shicheng Yang
• Apurva Krishna
• Srinivas Sridhar

Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages

in Microbial Immunology

• Cassandra L. R. van Doorn
• Sanne A. M. Steenbergen
• Kimberley V. Walburg
• Tom H. M. Ottenhoff

The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma

in Cancer Molecular Targets and Therapeutics

• Jerred P. Pletcher
• Sayani Bhattacharjee
• Jonathan P. Doan
• Rebecca Wynn
• Puneet Sindhwani
• Nagalakshmi Nadiminty
• Firas G. Petros

Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer

in Gynecological Oncology

• Sanat Kulkarni
• Ketankumar Gajjar
• Srinivasan Madhusudan

Virus–Host Interplay Between Poly (ADP-Ribose) Polymerase 1 and Oncogenic Gammaherpesviruses

in Virology

• Woo-Chang Chung
• Moon Jung Song

Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics

in Molecular and Cellular Pathology

• Iain A. Richard
• Joshua T. Burgess
• Kenneth J. O’Byrne
• Emma Bolderson

Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction

in Inflammation Pharmacology

• Qi Wang
• Tong Zhao
• Wei Zhang
• Wenbin Yu
• Bin Liu
• Zhaoyang Wang
• Wen Qiao
• Qinghua Lu
• Aihua Wang
• Mingxiang Zhang

Poly (ADP-Ribose) Polymerase 1 Regulates Cajal–Retzius Cell Development and Neural Precursor Cell Adhesion

in Cell Adhesion and Migration

• Megan M. Nelson
• J. Damon Hoff
• Mya L. Zeese
• Gabriel Corfas

Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington’s Disease

• Emanuela Paldino
• Antonella Cardinale
• Vincenza D’Angelo
• Ilaria Sauve
• Carmela Giampà
• Francesca R. Fusco

Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer

in Gynecological Oncology

• Qianying Zhao
• Liping Bai
• Yu Tan
• Mingrong Qie

Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury

in Inflammation

• Hye Ryoun Jang
• Kyungho Lee
• Junseok Jeon
• Jung-Ryul Kim
• Jung Eun Lee
• Ghee Young Kwon
• Yoon-Goo Kim
• Dae Joong Kim
• Jae-Wook Ko
• Wooseong Huh

Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305

in Pharmacology of Anti-Cancer Drugs

• Jingcao Zheng
• Zhengyu Li
• Wenjiao Min

Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Ovarian Cancer: A Systematic Review and Network Meta-Analysis

in Gynecological Oncology

• Jing Luo
• Shunlong Ou
• Hua Wei
• Xiaoli Qin
• Qian Jiang

Laser-Induced Nuclear Damage Signaling and Communication in Astrocyte Networks Through Parp-Dependent Calcium Oscillations

in Optics and Photonics

• Nicole M. Wakida
• Ryan D. Ha
• Edward K. Kim
• Xiangduo Kong
• Kyoko Yokomori
• Michael W. Berns

Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms

in Pharmacology of Anti-Cancer Drugs

• Jiqing Zhang
• Dan Ouyang
• Mu Liu
• Yuting Xiang
• Zhongjun Li